Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $821.6300 (1.16%) ($810.7900 - $821.6300) on Fri. Mar. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.9% (three month average) | RSI | 73 | Latest Price | $821.6300(1.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 4.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(43%) DIA(33%) VYM(30%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -0.95% in a week (0% probabilities). VXX(-25%) VIXM(-17%) TBT(-4%) UUP(-2%) ACES(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.95% (StdDev 1.9%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $819.82(0.22%) | 10 Day Moving Average | $800.33(2.66%) | 20 Day Moving Average | $779.33(5.43%) | To recent high | -0.5% | To recent low | 20.7% | Market Cap | $87.116b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |